12 employees
Xynomic Pharmaceuticals, Inc. is a clinical stage oncology-focused biopharmaceutical company.
2016
Xynomic Pharma raised undisclosed on June 1, 2018
Investors: 上海景旭创业投资有限公司, Northern Light Venture Capital and Hakim Information Technology Co., Ltd.